Galleri analyzes cell-free DNA methylation patterns to detect 50+ cancers, including many with no existing screening tests, with a ~1% false-positive rate and ~90% accuracy in pinpointing the cancer’s tissue of origin. It identifies signals years before symptoms appear, enabling earlier intervention when survival rates are dramatically higher. This makes it one of the most impactful adjunct screening tools for proactive, longevity-focused patients.

Prenuvo provides a radiation-free, head-to-toe MRI capable of detecting cancers, aneurysms, liver disease, disc herniations, and other structural pathology with up to ~94% sensitivity for solid tumors. Unlike traditional imaging, it uses advanced protocols optimized for early disease, not late-stage detection. It empowers patients with a single, comprehensive snapshot of organ, spine, and soft-tissue health to identify issues years before they cause symptoms.

ApoE testing identifies whether a patient carries the E2, E3, or high-risk E4 alleles, with E4 increasing lifetime Alzheimer’s risk up to 10–15× in E4/E4 carriers. Knowing genotype decades early enables targeted prevention—including lifestyle, vascular risk reduction, sleep optimization, and future therapeutic eligibility. For patients with family history or cognitive concerns, it is one of the most actionable precision-medicine biomarkers available.

Cleerly uses AI-powered coronary CT angiography to quantify total plaque burden, soft plaque, and high-risk “vulnerable” plaque, which traditional calcium scoring cannot detect. It provides a detailed map of stenosis severity and plaque composition, allowing physicians to catch heart disease at its earliest, reversible stages. Because soft plaque drives most heart attacks, Cleerly offers a major upgrade in cardiovascular prevention.

DEXA provides the gold-standard measurement for body composition and bone density, identifying osteopenia/osteoporosis early and quantifying visceral fat—one of the strongest predictors of metabolic disease. Resting metabolic rate testing shows how efficiently the body uses energy, enabling precise nutrition and weight-management planning instead of guesswork. VO₂-max, the most powerful predictor of long-term mortality, reveals cardiorespiratory fitness capacity and guides highly targeted exercise training for longevity.